Related Experiment Video
Updated: Jun 10, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Natural product-inspired [3 + 2] cycloaddition-based spirooxindoles as dual anticancer agents: synthesis,
Narayanasamy Nivetha1, Jevid Don Hamid1, Akshaya Simha N2
1Organic and Polymer Synthesis Laboratory, Department of Chemistry, National Institute of Technology Tiruchirappalli 620015 Tamil Nadu India velmathis@nitt.edu.
Abstract:
Breast and colorectal cancers are the most common tumors, with high recurrence and low survival rates. We designed and synthesized a series of spirooxindole pyrrolidinyl derivatives, which were further evaluated for anti-proliferative activity using MDA-MB-468 and HCT 15 cell lines. The best inhibitor of this class, compound 6f, showed a very good inhibition potency, both on the MDA-MB-468 and HCT 15 cells as confirmed by molecular docking and molecular dynamic studies that predicted its binding mode into the active site of the targets. In summary, this study provided a new anti-proliferative derivative 6f which is worthy of further research.
Insights
Researchers developed novel spirooxindole pyrrolidinyl derivatives to combat breast and colorectal cancers. Compound 6f demonstrated significant anti-proliferative activity against cancer cell lines, showing promise for future therapeutic development.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Biology
Background:
- Breast and colorectal cancers are leading causes of cancer mortality worldwide.
- High recurrence and low survival rates necessitate novel therapeutic strategies.
- Spirooxindole derivatives represent a promising class of compounds for drug discovery.
Purpose of the Study:
- To design and synthesize novel spirooxindole pyrrolidinyl derivatives.
- To evaluate the anti-proliferative activity of these compounds against breast (MDA-MB-468) and colorectal (HCT 15) cancer cell lines.
- To investigate the molecular interactions of the most potent compound with its target.
Main Methods:
- Synthesis of a series of spirooxindole pyrrolidinyl derivatives.
- In vitro anti-proliferative assays using MDA-MB-468 and HCT 15 cell lines.
- Molecular docking and molecular dynamic simulations to predict binding modes.
Main Results:
- Compound 6f exhibited potent anti-proliferative activity against both MDA-MB-468 and HCT 15 cancer cells.
- Molecular modeling studies confirmed the favorable binding of compound 6f within the active site of target proteins.
- The synthesized derivatives showed varying degrees of inhibition, with 6f being the most effective.
Conclusions:
- Compound 6f is a promising novel anti-proliferative agent for breast and colorectal cancers.
- The study provides a foundation for further development of spirooxindole derivatives as anticancer therapeutics.
- Detailed molecular insights into the mechanism of action of compound 6f were obtained.
Related Concept Videos
Cycloaddition Reactions: Overview
[4+2] Cycloaddition of Conjugated Dienes: Diels–Alder Reaction
Cycloaddition Reactions: MO Requirements for Thermal Activation
Cyclohexenones via Michael Addition and Aldol Condensation: The Robinson Annulation
Diels–Alder Reaction Forming Bridged Bicyclic Products: Stereochemistry
Cycloaddition Reactions: MO Requirements for Photochemical Activation
![Solid-phase Synthesis of [4.4] Spirocyclic Oximes](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58508.jpg&w=3840&q=50)
